AVTR - Avantor, Inc.
NEXT EARNINGS:
Apr 24, 2026
EPS Est: $0.16
|
Rev Est: $1.5B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$9.79
DETAILS
HIGH:
$11.00
LOW:
$8.00
MEDIAN:
$10.00
CONSENSUS:
$9.79
UPSIDE:
7.46%
Market Cap:
6.21B
Volume:
7,511,700
Avg Volume:
11,849,293
52 Week Range:
8.895-18.02
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.95
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
13,500
IPO Date:
2019-05-17
EPS (TTM):
-0.78
P/E Ratio:
-14.65
Revenue (TTM):
6.55B
Total Assets:
11.79B
Total Debt:
3.95B
Cash & Equiv:
365.40M
Rev Growth (5Y):
0.5%
EPS Growth (5Y):
43.6%
FCF Growth (5Y):
-10.6%
ROCE:
-2.6%
Debt/Equity:
0.71
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-11 | $0.22 | $0.21 | +4.8% | $1.7B | $1.6B | +6.7% |
| 2025-10-29 | $0.22 | $0.22 | -2.1% | $1.6B | $1.6B | -1.3% |
| 2025-08-01 | $0.24 | $0.25 | -4.0% | $1.7B | $1.6B | +2.3% |
| 2025-04-25 | $0.23 | $0.23 | -0.6% | $1.6B | $1.6B | -1.6% |
| 2025-02-07 | $0.27 | $0.25 | +8.0% | $1.7B | $1.7B | +1.4% |
| 2024-10-25 | $0.26 | $0.25 | +2.1% | $1.7B | $1.7B | -0.6% |
| 2024-07-26 | $0.25 | $0.23 | +7.6% | $1.7B | $1.7B | 0.0% |
| 2024-04-26 | $0.22 | $0.20 | +9.5% | $1.7B | $1.7B | -0.2% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.55B | 6.78B | 6.97B | 7.51B | 7.39B | 6.39B | 6.04B | 5.86B | 1.25B | 691.30M | 636.90M |
| Net Income | (530.20M) | 711.50M | 321.10M | 686.50M | 572.60M | 116.60M | 37.80M | (86.90M) | (112.70M) | (42.40M) | 21.60M |
| EPS | -0.78 | 1.05 | 0.48 | 1.02 | 0.86 | 0.09 | -0.84 | -0.72 | -0.84 | -0.09 | 0.04 |
| Total Assets | 11.79B | 12.11B | 12.97B | 13.46B | 13.90B | 9.91B | 9.77B | 9.91B | 10.45B | 1.14B | N/A |
| Total Debt | 3.95B | 4.23B | 5.54B | 6.29B | 7.02B | 4.89B | 5.12B | 6.92B | 7.12B | 1.30B | N/A |
| Cash & Equivalents | 365.40M | 261.90M | 262.90M | 372.90M | 301.70M | 286.60M | 186.70M | 184.70M | 185.40M | 62.90M | N/A |
| Operating Cash Flow | 623.80M | 840.80M | 870.00M | 843.60M | 953.60M | 929.80M | 354.00M | 200.50M | (167.50M) | 72.90M | 124.60M |
| Free Cash Flow | 495.00M | 692.00M | 723.60M | 710.20M | 842.50M | 868.20M | 302.40M | 162.80M | (192.70M) | 43.00M | 103.70M |
| FCF per Share | 0.73 | 1.02 | 1.07 | 1.09 | 1.43 | 1.51 | 0.75 | 0.33 | -0.39 | 0.09 | 0.19 |
| Book Value | 5.57B | 5.96B | 5.25B | 4.86B | 4.20B | 2.67B | 2.46B | (3.05B) | (2.62B) | (374.90M) | N/A |
| Cash & ST Investments | 365.40M | 261.90M | 262.90M | 372.90M | 301.70M | 286.60M | 186.70M | 184.70M | 185.40M | 62.90M | N/A |
| ROC Equity | -0.10 | 0.12 | 0.06 | 0.14 | 0.14 | 0.04 | 0.02 | N/A | N/A | N/A | N/A |